Literature DB >> 22767402

Structure-directing agents for the synthesis of TiO(2) -based drug-delivery systems.

Elena Ghedini1, Valentina Nichele, Michela Signoretto, Giuseppina Cerrato.   

Abstract

A series of titanium oxides was prepared by using a surfactant-template method (STM) and used as a carrier for the sustained release of ibuprofen, which was chosen as a model drug. This STM provides an efficient route to TiO(2) matrices with both high surface area (when compared with those that were obtained by using traditional synthetic approaches) and well-defined mesoporous textures. Some parameters of the synthetic procedure were varied: pH value, surfactant, and thermal treatment. The physicochemical nature of the surface carriers were investigated by means of N(2) -physisorption measurements and FTIR spectroscopy. The effect of the amount of drug on the release kinetics was also investigated. The drug delivery was evaluated in vitro in four different physiological solutions (that simulated the gastrointestinal tract) to analyze the behavior of the TiO(2) -based systems if they were to be formulated as oral DDSs. Our optimized approach is a good alternative to the classical methods that are used to prepare efficient TiO(2) -based drug-delivery systems.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767402     DOI: 10.1002/chem.201201355

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Multifunction hexagonal liquid-crystal containing modified surface TiO2 nanoparticles and terpinen-4-ol for controlled release.

Authors:  Eloísa Berbel Manaia; Renata Cristina Kiatkoski Kaminski; Anselmo Gomes de Oliveira; Marcos Antonio Corrêa; Leila Aparecida Chiavacci
Journal:  Int J Nanomedicine       Date:  2015-01-22

Review 2.  Porous TiO₂-Based Gas Sensors for Cyber Chemical Systems to Provide Security and Medical Diagnosis.

Authors:  Vardan Galstyan
Journal:  Sensors (Basel)       Date:  2017-12-19       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.